Advanced cellular immunotherapy for modern oncology.

Discover innovative cellular therapies that strengthen the immune response against treatment-resistant tumors.

Advanced cellular immunotherapy based on Natural Killer cells designed to enhance the anti-tumor immune response, overcome tumor evasion mechanisms and support innovative therapeutic strategies in modern clinical oncology.

Request technical and commercial information about our cellular therapies for specialized oncology.

Location
Lope de Vega 117, Polanco, Polanco V Secc, Miguel Hidalgo, 11560 Ciudad de México, CDMX
Depiction of a Natural Killer cell connected to a neural network

Ready to set your oncology practice apart?

Discover cellular therapies to expand clinical options for complex tumors.

Clinical benefits for your practice

Gencell Oncology offers cellular therapies for physicians who require new alternatives in complex tumors, providing technical support, therapeutic differentiation, and guidance for more precise clinical decision-making.

Where do we generate the greatest value?

0 +

+

Key therapies for modern specialized oncology.

A portfolio designed to expand therapeutic options, differentiate your practice, and facilitate the evaluation of patients with complex oncologic disease.

Strategic benefits for specialized oncology.

We integrate cellular therapies with clinical value, scientific support, and therapeutic differentiation for physicians who require alternatives in complex tumors, refractory scenarios, and patients who demand more precise clinical decision-making.

NK therapies promote the identification of malignant cells, activate cytotoxic degranulation, and contribute to a more effective antitumor immune response.

The portfolio includes autologous, allogeneic, and dual-blockade therapies to select the most appropriate alternative according to the patient’s immunological condition and tumor complexity.

Integrate advanced therapies that provide medical differentiation, technical support, and an innovative proposal for patients with difficult-to-manage oncologic conditions.

Clinical benefits that support your therapeutic decision-making

Gencell Oncology develops therapies with autologous Natural Killer cells, allogeneic Natural Killer cells, and dual blockade strategies for physicians who require innovative alternatives in resistant tumors, immunosuppressed patients, and neoplasms with immune evasion mechanisms.

Depiction of Natural Killer cells attacking tumor cells

Request professional guidance and discover which therapy may best fit your patients.

Precision oncology with advanced cellular immunotherapy.

Explore a new therapeutic line for your practice.

Access a portfolio developed for specialist physicians who need innovative therapeutic tools to strengthen their clinical approach and expand treatment possibilities.

Product portfolio

Syringe of autologous Natural Killer Cell NK5 by Gencell Oncology

Autologous Natural Killer Cells

Therapy with pretreated autologous NK cells aimed at enhancing the immune response and improving tumor visibility in complex neoplasms.

Syringe of heterologous Natural Killer Cell NK5 by Gencell Oncology

Heterologous Natural Killer Cells

Alternative using NK cells from a qualified donor for patients who are immunosuppressed or undergoing treatments that compromise immune activity.

Syringe of heterologous Double Blockade Natural Killer by Gencell Oncology

NK Heterologous Blockade

High-potency heterologous therapy designed to strengthen the immune response in complex patients requiring greater antitumor activation.

Syringe of autologous Double Blockade Natural Killer by Gencell Oncology

NK Autologous Blockade

Combination of autologous NK cells with nivolumab and ipilimumab to overcome immune evasion and expand options in refractory or advanced tumors.

Looking for a therapy aligned with your patient’s clinical profile? Request specialized guidance.

New therapeutic alternatives for oncologists seeking real clinical differentiation.

Access cellular therapies with clear benefits, technical support, and differential value to expand options for complex tumors, immune evasion, and scenarios where more innovative oncological approaches are required.

Greater clinical value

Strengthen your practice with innovative therapies for specialized oncology and real medical differentiation.

Therapeutic benefits

Explore products designed to expand options for complex and treatment-resistant tumors.

Scientific background

Review mechanisms of action and technical data sheets with valuable information for specialized medical evaluation.

Specialized portfolio

Discover NK therapies designed for oncologists seeking therapeutic innovation and distinctive clinical value.

¿Te ayudamos?

Déjanos tus datos y un asesor te contacta. Sin compromiso.

Al enviar aceptas que Gencell te contacte. Tus datos no se comparten con terceros.

¡Gracias!

Hemos recibido tus datos. Un asesor te contacta en breve.